Neurogene (NGNE) Other Non-Current Assets (2013 - 2026)

Neurogene (NGNE) reported Other Non-Current Assets of $300000.0 for Q1 2026, little changed on a YoY basis from $300000.0 in Q1 2025, and down 11.5% quarter-over-quarter from $339000.0 in Q4 2025.

Neurogene (NGNE) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Neurogene has reported Other Non-Current Assets for 13 years, with the latest figure at $300000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at $300000.0 (changed 0.0% YoY), and the FY2025 full-year result was $339000.0, down 65.23% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $300000.0, down from $339000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.0 million in Q2 2022, with the low at $300000.0 in Q3 2024.
  • Historically, Other Non-Current Assets has averaged $814250.0 across 5 years, with a median of $636000.0 in 2023.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets slumped 73.81% — and 2024, when it soared 50.09%.
  • Neurogene's Other Non-Current Assets stood at $1.9 million in 2022, then tumbled by 60.04% to $764000.0 in 2023, then advanced by 27.62% to $975000.0 in 2024, then sank by 65.23% to $339000.0 in 2025, then slipped by 11.5% to $300000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $300000.0 (Q1 2026), $339000.0 (Q4 2025), and $339000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Neurogene 216.17 Mn 216.17 Mn - 300,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 300,000.00
Dec 31, 2025 339,000.00
Sep 30, 2025 339,000.00
Jun 30, 2025 339,000.00
Mar 31, 2025 300,000.00
Dec 31, 2024 975,000.00
Sep 30, 2024 300,000.00
Jun 30, 2024 794,000.00
Mar 31, 2024 743,000.00
Dec 31, 2023 764,000.00
Sep 30, 2023 524,000.00
Jun 30, 2023 529,000.00
Mar 31, 2023 905,000.00
Sep 30, 2022 1.91 Mn
Jun 30, 2022 2.02 Mn
Mar 31, 2022 1.95 Mn
Dec 31, 2021 1.93 Mn
Sep 30, 2021 1.99 Mn
Jun 30, 2021 1.93 Mn
Mar 31, 2021 1.92 Mn